Epithelioid mesothelioma is a rare cancer caused by asbestos. It accounts for 50% to 70% of all cases, making it the most common mesothelioma cell type. Epithelial mesothelioma develops in the lining of the lungs, abdomen or heart. Life expectancy with treatment ranges from 14.4 months to 51.5 months.
Learn more about mesothelioma, asbestos and the steps you can take to fight this disease.
"The Patient Advocates are absolutely amazing and helpful! I am so very pleased with the information and the emotional support that I have received from everyone...." see more
Pamela K.
Mesothelioma Patient
"I found out about The Mesothelioma Center while researching peritoneal mesothelioma days after being diagnosed with the malignant cancer. While a lot of the 'Me...." see more
Karen F.
Mesothelioma Patient
"I reached out and talked to Aaron a couple of weeks before my diagnosis of malignant mesothelioma. He was very helpful and gave me a lot of information at that ...." see more
Stan B.
Mesothelioma Patient
"My brother was recently diagnosed with mesothelioma. I began researching it online. The information I received from The Mesothelioma Center is all-inclusive. No...." see more
Cindy W.
Sister of a Mesothelioma Patient
"My Dad was diagnosed with mesothelioma, and thankfully The Mesothelioma Center was the first place I called. Snehal Smart answered the phone immediately and was...." see more
Epithelial mesothelioma is a type of cancer that develops in the mesothelium. This protective tissue lines vital organs. Asbestos irritates this tissue and is the primary cause of epithelioid mesothelioma.
Epithelial mesothelioma, or epithelioid mesothelioma, is the most common mesothelioma cell type. It can develop in the lining of the lungs (pleural), abdomen (peritoneal), heart (pericardial) or testes (testicular). Epithelial cells are long (columnar) or square (cuboidal). They indicate a favorable mesothelioma prognosis.
Key Facts About Epithelioid Mesothelioma
Epithelial mesothelioma is the most common cell type, accounting for 50% to 70% of all cases.
Doctors diagnose 1,500 to 2,100 epithelioid mesothelioma patients annually.
Epithelial mesothelioma is primarily caused by asbestos exposure.
Life expectancy of patients with epithelial mesothelioma is longer than for those with biphasic or sarcomatoid cell types. Epithelial cells respond better than others to aggressive treatment.
What Causes Epithelioid Mesothelioma?
Asbestos exposure is the primary cause of epithelioid mesothelioma. Inhaling or ingesting asbestos fibers causes tissue inflammation and DNA damage. This can lead to cancer decades later.
Asbestos fibers cause inflammation in the mesothelium. This lining is made of tissue called epithelium because it’s made of epithelial cells.
The risk factors primarily involve different sources of asbestos exposure. Most people with epithelioid mesothelioma worked with asbestos products before their diagnosis. All mesothelioma cell types have a latency period of 20 to 60 years. The first symptoms may not appear for decades after the initial asbestos exposure. Some people also develop mesothelioma from secondhand exposure.
Malignant epithelial mesothelioma survivor Christine S. told The Mesothelioma Center her dad mixed asbestos cement at work when she was a little girl. She and her mom washed his clothes. She never thought that could cause her own cancer decades later in 2007.
Christine S.
Verified Asbestos.com Survivor
Facing Malignant Epithelial Mesothelioma
Christine S. was diagnosed with epithelial malignant mesothelioma on October 11, 2007. She had multiple rounds of chemotherapy. Six of them used Alimta. It helped shrink her cancer. She stressed the benefits of medical advice and accepted her diagnosis.
Symptoms of Epithelioid Mesothelioma
Epithelioid mesothelioma symptoms often include cough, shortness of breath and lack of appetite. As the disease progresses, more severe symptoms may appear. Many symptoms depend on tumor location and size.
Common Symptoms of Epithelioid Mesothelioma
Abdominal pain or bloating
Bowel or bladder changes
Chest tightness or pain
Cough, hoarseness or difficulty swallowing
Difficulty breathing
Fatigue
Fever or night sweats
Fluid buildup in the chest or abdomen (effusion)
Loss of appetite
Nausea, vomiting or diarrhea
Unexplained weight loss
Mesothelioma cancer symptoms are the same, no matter the cell type. Patients with different cell types experience the same symptoms. But the cell type affects which treatments are most helpful. Talk to your doctor if you experience any of these symptoms.
Find a Top Mesothelioma Doctor
Gain access to top mesothelioma doctors and get help scheduling appointments.
A tissue biopsy is the only way to diagnose epithelial mesothelioma. This procedure samples suspicious tissue to confirm the cell type under a microscope. Epithelial mesothelioma cells clump together in groups and don’t tend to travel. These cell types are less likely to spread to other areas of the body.
“Epithelial subtype mesothelioma describes the type of cells the pathologist is seeing under the microscope when they look at a patient’s tumor,” mesothelioma specialist Dr. Andrea Wolf of Mount Sinai Hospital told The Mesothelioma Center at Asbestos.com.
Diagnosing Epithelial Mesothelioma
Diagnosing epithelioid mesothelioma requires a biopsy.
Imaging scans can show abnormalities, but they alone cannot diagnose cancer.
Blood tests aren’t helpful for diagnosis, but research is ongoing to make them more effective.
After a biopsy, the pathologist will create a report for your physician. The pathology report describes the mesothelioma cells found in a patient’s tumors. Pathologists use immunohistochemistry tests to identify certain proteins associated with epithelial cells.
Many patients call us to ask questions about their mesothelioma diagnosis. They usually don’t know their cell type. It’s important to ask your doctor about cell type. This will help you understand your symptoms, treatment and prognosis.
Survivor Christine S. told us doctors performed X-rays and other scans because her lungs kept filling up with fluid. Finally, a doctor at another hospital ordered a biopsy. “The result of the biopsy was mesothelioma,” Christine said.
Epithelial Cell Subtypes
Pathologists can identify epithelioid cell subtypes with immunohistochemistry. A specific subtype can influence your treatment options or mesothelioma prognosis. Rare subtypes could lead to a misdiagnosis. Some epithelioid cell subtypes are linked to a better mesothelioma survival rate. The adenomatoid cell type is an example.
Adenomatoid
Also known as the microglandular cell type, this accounts for only 6% of pleural cases. The peritoneal form behaves like benign lesions and responds well to treatment.
Deciduoid
Doctors have diagnosed fewer than 50 cases of this very rare subtype. It most often affects young women. Just more than 50% of deciduoid cases occur in the abdomen, and less than 50% occur in the pleura. It can be mistaken for other cancers, including a type of lung cancer known as squamous cell.
Glandular
Glandular tumors often develop in the pleura and have patterns that resemble glands. These cells behave like a type of cancer called adenocarcinoma that has spread to the pleura.
Small Cell
Small cell mesothelioma doesn’t show the patterns found in small cell lung cancer. Those patterns include stream, ribbon or rosette. This cell type occurs with greater frequency in the abdomen. The survival rate is around 8 months.
Solid
Well-differentiated solid cells group in nests, cords or sheets. They resemble noncancerous abnormal cell growth. Poorly differentiated cells may look like large cell carcinoma or lymphoma.
Tubulopapillary
This common epithelial subtype can resemble a cancer called adenocarcinoma of the pleura. It’s not the same as benign well-differentiated papillary mesothelioma.
Talk to your mesothelioma doctor about your cell type, cancer stage and speed of tumor growth. Ask how these factors affect your treatment plan and prognosis.
Treatment Options for Epithelioid Mesothelioma
Your treatment will depend on the cancer stage, tumor extent and overall health. Doctors often treat epithelioid mesothelioma with a mix of therapies. This is called multimodal therapy.
Early-stage cases typically get aggressive treatment with surgery, chemotherapy and radiation therapy. Late-stage cases respond better to palliative care. This may include immunotherapy, chemotherapy and Tumor Treating Fields therapy.
Common Epithelioid Mesothelioma Treatments
Chemotherapy can triple the mesothelioma survival rate.
Immunotherapy can extend survival to 18 months for many patients.
Radiation therapy helps manage symptoms and prevent local recurrence.
Surgery extends survival an average of 2 years or 5 years after HIPEC.
Of the 3 cell types, epithelial mesothelioma responds best to treatment. “The epithelial type does tend to be more favorable,” explains Dr. Wolf. “It does tend to respond to chemotherapy a little more easily.”
Patients may consider a second opinion at a top cancer center. The specialists at these centers have the best experience. They can offer clinical trials and multimodal treatment.
Get a Free Mesothelioma Guide
Learn about your diagnosis, top doctors and how to pay for treatment.
The epithelioid mesothelioma prognosis is better than the outlook for biphasic and sarcomatoid cells. Epithelioid cells respond the best to treatment. They don’t spread as quickly as the other cell types, translating into longer survival. Some patients who receive multimodal therapy using two or more treatments live longer.
The 5-year survival rate for epithelioid pleural mesothelioma is 12%. A peritoneal mesothelioma study found a median survival of 55 months in epithelioid patients. Those with sarcomatoid or biphasic cells had a median survival of 7 to 13 months.
It pays to try and stay calm, easier said than done, and go through whatever treatment you have to in order to live longer. And I try to live my life involving family and friends as best I can.
Epithelioid patients live 200 days longer on average than patients with other cell types. The average life expectancy of epithelial mesothelioma patients is 18 months. Duration of asbestos exposure can also affect prognosis and life expectancy. Early detection and diagnosis at a younger age improve the prognosis. The overall survival of all cell types drops when the disease metastasizes or spreads.
Common Questions About Epithelioid Mesothelioma
Is epithelioid mesothelioma the same as epithelial mesothelioma?
Yes, epithelioid mesothelioma and epithelial mesothelioma refer to the same subtype of mesothelioma. Both terms are used interchangeably in medical contexts.
Where can I get treatment for epithelial cell mesothelioma?
The nation’s top cancer centers have the best resources to treat epithelial mesothelioma. Look for mesothelioma specialists with years of experience treating pleural and peritoneal mesothelioma. Oncologists need training to treat this cell type. Our Patient Advocates and our Doctor Match program can help you find a top doctor who treats epithelial mesothelioma.
Can epithelioid mesothelioma be prevented?
Asbestos exposure is the primary cause of mesothelioma. Avoiding it is the best way to prevent mesothelioma. If you have a history of asbestos exposure, talk to your doctor about cancer screenings. These may aid in an early diagnosis.
Is epithelioid mesothelioma curable?
Unfortunately, epithelioid mesothelioma has no cure. But patients with the epithelioid cell type have the most treatment options. This cell type responds best to all forms of treatment.
Are there clinical trials available for epithelioid mesothelioma?
Researchers look for mesothelioma patients with the epithelioid cell type for clinical trials. These patients have the disease’s most common cell type. Researchers want to know how a treatment will affect most patients with mesothelioma.
Is epithelioid mesothelioma hereditary?
Epithelioid mesothelioma is not considered hereditary. Certain genes may increase the risk of developing mesothelioma after asbestos exposure. Asbestos exposure, not inheritance, is the primary cause of this cancer.
The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.
Liou, D., Wang, Y. & Bhandari, P. (2023). Impact of guideline therapy on survival of patients with stage I–III epithelioid mesothelioma. Retrieved from https://jtd.amegroups.org/article/view/81618/html
Kusamura, S. et al. (2023, January 21). Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma. Retrieved from https://www.mdpi.com/2072-6694/15/3/662
Dumoulin, D.W. et al. (2022, October 18). Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours. Retrieved from https://err.ersjournals.com/content/errev/32/167/220174.full.pdf
Stevers, M. et al. (2018, August 31). Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42. Retrieved from https://www.nature.com/articles/s41379-018-0127-2
Kindler, H.L. et al. (2018, May 1). Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline. Retrieved from https://ascopubs.org/doi/pdf/10.1200/JCO.2017.76.6394
Amin, W. et al. (2018). Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort. Retrieved from https://f1000research.com/articles/7-1184/v3
Yaziji, H. et al. (2006, April). Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximum sensitivity and specificity. Retrieved from https://www.modernpathology.org/article/S0893-3952(22)03380-4/fulltext
Recommended Reading
Tell us what you think
Did this article help you?
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?
Thank you for your feedback. Would you like to speak with a Patient Advocate?
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
Who Am I Calling?
Calling this number connects you with a Patient Advocate at The Mesothelioma Center, the nation's most trusted mesothelioma resource.
Our Patient Advocates can help guide you or your loved one through the steps to take after a mesothelioma diagnosis. Our team has a combined experience of more than 30 years in assisting cancer patients, and includes a medical doctor, an oncology registered nurse and a U.S. Navy veteran.
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Reviewed
Asbestos.com is the nation’s most trusted mesothelioma resource
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
About The Mesothelioma Center at Asbestos.com
Assisting mesothelioma patients and their loved ones since 2006.
Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
A+ rating from the Better Business Bureau.
5-star reviewed mesothelioma and support organization.
My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.
Asbestos.com. (2024, November 11). Epithelioid Mesothelioma. Retrieved November 20, 2024, from https://www.asbestos.com/mesothelioma/malignant/epithelial/
MLA
"Epithelioid Mesothelioma." Asbestos.com, 11 Nov 2024, https://www.asbestos.com/mesothelioma/malignant/epithelial/.
Chicago
Asbestos.com. "Epithelioid Mesothelioma." Last modified November 11, 2024. https://www.asbestos.com/mesothelioma/malignant/epithelial/.
A medical doctor who specializes in mesothelioma or cancer treatment reviewed the content on this page to ensure it meets current medical standards and accuracy.
Please read our editorial guidelines to learn more about our content creation and review process.
Dr. Jacques Fontaine is a thoracic surgeon at Moffitt Cancer Center in Tampa, Florida, where he heads up the Mesothelioma Research and Treatment Center. He specializes in minimally invasive robotic surgery and aggressive surgeries for mesothelioma.
California Consumer Privacy Act (CCPA) Inquiries
Mesothelioma Center - Vital Services for Cancer Patients & Families doesn’t believe in selling customer information. However, as required by the new California Consumer Privacy Act (CCPA), you may record your preference to view or remove your personal information by completing the form below.